Sofina Ventures SA has made another notable secondary market sale, selling a part stake in its digital-first holding company Mamaearth, a personal care brand. The block transaction, which was part of a bulk sale in the National Stock Exchange, is part of a larger trend of late-stage global venture capital and private equity firms seeking systematic avenues for monetizing their India-listed mature investments. This partial sale by an early institutional investor lends liquidity to the firm and helps to restructure the consumer company’s capitalization table during the expansion stage after listing.
Open market operation and pricing
Official equity exchange data showed that the VC firm sold 41.78 lakh shares, corresponding to 1.28% stake in the paid-up capital of Honasa Consumer. The net transaction value of the selling fund from the large-scale open market operation was approximately ₹177.2 crore at an average price of ₹424.07 per share.
The offer price was slightly higher than the previous day’s closing stock price. It suggests that the institutional buyer on the receiving side of the counter was willing to pay a slight premium for a relatively large block of equity, rather than disrupt the general market stability.
The share sale represents a meaningful change in Sofina Ventures’ historically held shares in the consumer house of brands. Before the bulk deal, the power of Sofina Ventures in Honasa Consumer was shown as 3.29%, as per shareholding data released during the March quarter of 2026.
After the block sale to the open market of its 1.28% stake, the institutional investor’s total stake in the direct-to-consumer beauty firm is now estimated to be around 2.01%. This decrease in investment does not diminish the overall investment interest that the fund has maintained in the growth progression of the company since its previous private placement efforts.
Regional acquisition and venture capital monetization
Retail players and market watchers see the recent move by Sofina Ventures as a routine facet of the business’s operational cycle, and not as an indicator of its health. Early-stage institutional giants frequently sell off portions of their stakes following significant gains in stock prices to restate their global portfolios and distribute funds back to their limited partners.
The move is similar to a series of secondary offerings conducted by international investment conglomerates taking advantage of the liquidity of listed Indian startups. In the recent past, there have been multiple sell-offs taking place in the domestic tech sector, with Actis striking bulk deals in Pine Labs, Alpha Wave unwinding its holding in Delhivery and partial exits by SoftBank and the Abu Dhabi Investment Authority in eyewear major Lenskart.
The bulk deal was executed at a time when Honasa Consumer’s operations were strong, and the financial growth was gaining pace. Honasa Consumer has reported a total revenue from operations of ₹657 crore for the fiscal year 2026 as of March 31, 2026. This marks an increase of 23% from ₹534 crore recorded in the previous year.
The net profit after tax saw a significant increase from the value it recorded for the similar period last year, at ₹25 crore, to the current value of ₹69.4 crore, indicating the effectiveness of the internal margin optimization and distribution expansion initiatives that the company has undertaken. The house of brands’ personal care business has not been sitting still on the corporate side of its inorganic arrangements efforts and has expanded its business lineup to master a segment beyond its main personal care brand of Mamaearth.
Honasa Consumer had already acquired a dominant 58% stake in hair therapy and nutraceuticals specialist Fluence Pharma earlier this week, on the same week as the block deal. It is the company’s second significant strategic acquisition of a business in six months, coming in quick succession of the previous acquisition of Regimental Men, which effectively took the platform into the highly growth-oriented men’s grooming segment.
Conclusion
The successful block sale from ₹177 crore stands out as a testament both to the maturity of Honasa Consumer as a liquid, publicly traded asset and to the continuous rebalancing process of the early institutional shareholders. For Sofina Ventures, the equity stake has been reduced to around 2%, though the transaction was executed quietly at a premium, reflecting the strong institutional belief in the fundamentals of the direct-to-consumer business model.
The company is financially well-positioned, with revenue growth of 23% year-over-year in the fourth quarter of the 2026 fiscal year and stealth acquisitions of product brands such as Fluence Pharma, Reginald Men, et al. contributing to its structural strength.
Read the full article here